View Article

Abstract

Wolcott–Rallison syndrome is a rare inherited disorder characterized mainly by permanent neonatal diabetes mellitus and multisystem complications. It is commonly associated with mutations in the Eif2AK3 gene and is inherited in an autosomal recessive manner. A 2year-old male child presented with poor feeding, excessive thirst, frequent urination, recurrent fever, vomiting, poor weight gain, and dehydration. Investigations revealed persistent hyperglycemia, elevated liver enzymes, and features suggestive of skeletal abnormalities. The child was managed with insulin therapy, fluid and electrolyte management, nutritional support, monitoring of liver function, and supportive care. Nursing management focused on blood glucose monitoring, hydration, nutrition, prevention of complications, growth monitoring, medication administration, and parental education. Early diagnosis and multidisciplinary management are important to improve outcomes and quality of life in children with Wolcott–Rallison syndrome.

Keywords

inherited autosomal recessive disorder, skeletal abnormalities, multisystem complications

Introduction

× Popup Image

Wolcott–Rallison syndrome (WRS) is a rare inherited disorder characterized mainly by permanent neonatal diabetes mellitus associated with skeletal abnormalities and episodes of acute liver dysfunction. It is usually caused by mutations in the EIF2AK3 gene and follows an autosomal recessive pattern of inheritance. Children with WRS may develop diabetes during the first months of life and may later develop recurrent episodes of liver dysfunction, skeletal abnormalities, growth retardation, and other complications. Early diagnosis, insulin therapy, monitoring of blood glucose, nutritional support, and management of complications are important for improving the child's health.1

Literature review:

Julier and Nicolino published a review article on Wolcott–Rallison syndrome in the Orphanet Journal of Rare Diseases. They described it as a rare autosomal recessive disorder characterized by permanent neonatal diabetes mellitus, skeletal dysplasia, and growth retardation. The authors explained that mutations in the EIF2AK3 gene are responsible for the disorder. They also highlighted the importance of early diagnosis, insulin therapy, monitoring of liver function, and genetic counselling.

Memon et al. (2022)Memon and colleagues reported three patients with Wolcott–Rallison syndrome in Pediatric Endocrinology, Diabetes and Metabolism. The patients presented with early-onset diabetes, and genetic testing identified EIF2AK3 mutations. The study highlighted the importance of genetic testing in children who develop diabetes during the first six months of life. The authors also emphasized regular monitoring for liver dysfunction and other complications.

Aldrian et al. (2024)Aldrian and colleagues published a systematic review and follow-up study on Wolcott–Rallison syndrome in Liver International. Their study reviewed the clinical features and complications of the disorder, including neonatal diabetes, liver dysfunction, growth impairment, and skeletal abnormalities. The findings demonstrated that the condition can affect multiple organs and that the severity varies among patients. The authors emphasized early recognition, regular follow-up, and multidisciplinary management.2,6

Definition:

Wolcott–Rallison syndrome is a rare autosomal recessive genetic disorder characterized primarily by permanent neonatal diabetes mellitus, with additional features such as skeletal abnormalities, growth retardation, and recurrent episodes of liver dysfunction.1,6

Etiology and Risk factor :

The major cause of Wolcott–Rallison syndrome is a pathogenic mutation in the EIF2AK3 gene. The EIF2AK3 gene produces a protein involved in the cellular response to endoplasmic-reticulum stress. Dysfunction of this pathway particularly affects pancreatic beta cells and other tissues Inheritance. Autosomal recessive inheritance. Both parents are usually carriers of the abnormal gene. The disorder can occur when a child inherits an abnormal copy of the gene from both parents.

Possible risk factors include:

  • Family history of Wolcott–Rallison syndrome
  • Consanguineous marriage
  • Parents carrying pathogenic EIF2AK3 variants
  • Previous child affected by neonatal diabetes associated with WRS
  • Family history of unexplained neonatal diabetes or early childhood liver dysfunction3,6

Pathophysiology:

EIF2AK3 gene mutation

↓

Abnormal cellular response to endoplasmic-reticulum stress

↓

Pancreatic beta-cell dysfunction

↓

Reduced insulin production

↓

Permanent neonatal diabetes mellitus

↓

Cellular stress and dysfunction in other organs

↓

Liver dysfunction + skeletal abnormalities + growth impairment

↓

Recurrent episodes of illness and metabolic complications2,3

Clinical Manifestation:

  • Permanent neonatal diabetes mellitus
  • Hyperglycemia
  • Excessive thirst
  • Frequent urination
  • Poor weight gain
  • Growth retardation
  • Recurrent fever
  • Vomiting
  • Dehydration
  • Episodes of acute liver dysfunction
  • Elevated liver enzymes
  • Skeletal abnormalities
  • Osteopenia or other bone abnormalities
  • Muscle weakness3,4

Diagnostic Evaluation :

A. Blood investigations

  • Blood glucose
  • HbA1c
  • Serum electrolytes
  • Liver function tests
  • Renal function tests
  • Complete blood count

B. Diabetes-related investigations

  • Fasting/random blood glucose
  • Urine glucose
  • Urine ketones when indicated
  • C-peptide assessment where appropriate

C. Imaging

  • X-ray of bones when skeletal abnormalities are suspected
  • Abdominal ultrasound for assessment of liver and other abdominal organs

D. Genetic testing

  • Genetic testing can identify pathogenic variants in the EIF2AK3 gene and help confirm the diagnosis

Medical Management:

A. Insulin therapy

  • Regular insulin administration as prescribed
  • Frequent monitoring of blood glucose
  • Adjustment of insulin according to glucose levels, nutrition, and illness

B. Fluid and electrolyte management

  • Assess hydration status
  • Provide oral or IV fluids as prescribed
  • Monitor electrolytes

C. Management of liver dysfunction

  • Regular liver function monitoring
  • Identify and treat precipitating factors
  • Supportive management during acute episodes

D. Nutritional management

  • Adequate calories and protein
  • Age-appropriate diet
  • Monitor weight and growth
  • Dietary planning according to insulin therapy

E. Management of skeletal abnormalities

  • Monitor bone health
  • Adequate calcium and vitamin D when prescribed
  • Physiotherapy where required.1,4,5

Nursing Management:

I. Assessment

  • Monitor vital signs.
  • Monitor blood glucose regularly.
  • Assess hydration status.
  • Monitor intake and output.
  • Assess nutritional status.
  • Record daily/regular weight.
  • Observe for signs of hypoglycemia and hyperglycemia.
  • Monitor for vomiting and fever.
  • Observe for signs of liver dysfunction.
  • Assess physical growth and development.
  • Assess mobility and skeletal abnormalities.
  • Monitor laboratory investigations.

II. Nursing interventions

  • Administer insulin as prescribed.
  • Monitor blood glucose before meals and as ordered.
  • Observe for symptoms of hypoglycemia.
  • Encourage adequate fluid intake when appropriate.
  • Maintain accurate intake and output records.
  • Provide prescribed nutritional support.
  • Monitor weight and growth.
  • Administer medications as prescribed.
  • Maintain infection-control measures.
  • Provide comfort during episodes of fever or illness.
  • Monitor liver function results.
  • Encourage appropriate physical activity according to the child's condition.
  • Maintain a safe environment to prevent injury.
  • Provide emotional support to the child and parents

Nursing Diagnosis:

1) Risk for unstable blood glucose level related to impaired insulin production.

2) Deficient fluid volume related to increased urinary fluid loss secondary to hyperglycemia.

3) Imbalanced nutrition: less than body requirements related to metabolic abnormalities and inadequate intake.

4) Delayed growth and development related to chronic metabolic disorder.

5) Risk for injury related to hypoglycemic episodes and skeletal abnormalities.

6) Anxiety of parents related to the child's chronic genetic condition and long-term treatment requirements.5

Nursing Care Plan

Nursing diagnosis Goals/
Expected outcomes
Nursing
Intervention
Rationale Evaluation
Risk for unstable blood glucose level Child will maintain blood glucose within prescribed target range. Monitor glucose;
Administer insulin;
Observe for hypo/hyperglycemia
Helps maintain glucose control and prevent complications Blood glucose improves
Risk for unstable blood glucose level Child will maintain adequate hydration
improves
Monitor I/O
Mucous membranes, urine output
provide fluids as prescribed
Prevents dehydration and electrolyte imbalance Hydration improves
Imbalanced nutrition: less than body requirements Child will achieve adequate
Nutrional intake &weight gain
Monitor weight;
Provide small frequent meals;
Collaborate with dietitian
Supports growth and metabolic needs Weight and intake improve
Delayed growth and development Child will show appropriate developmental progress Monitor height/weight;
Encourage developmental activities;
Refer when needed
Early intervention supports development Development monitored
Anxiety of parents Parents will verbalize reduced anxiety and understanding Provide information;
Allow questions;
Provide emotional support; explain treatment
Knowledge improves coping and confidence Parents demonstrate understanding

CONCLUSION:

Wolcott–Rallison syndrome is a rare inherited disorder characterized mainly by permanent neonatal diabetes mellitus with multisystem complications. Early identification of the condition is important for appropriate management. Nursing care focuses on maintaining blood glucose, hydration, nutrition, growth, safety, and early recognition of complications. Proper parent education and multidisciplinary follow-up are essential for long-term care.1,4,6

REFERENCES

  1. Julier C, Nicolino M. Wolcott-Rallison syndrome. Orphanet J Rare Dis. 2010;5:29. doi:10.1186/1750-1172-5-29.
  2. Delepine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet. 2000;25 (4):406-409. doi:10.1038/78085.
  3. Senee V, Vattem KM, Delepine M, Rainbow LA, Haton C, Lecoq A, et al. Wolcott-Rallison syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes. 2004;53 (7):1876-1883. doi:10.2337/diabetes.53.7.1876.
  4. Aldrian S, et al. Natural history of Wolcott-Rallison syndrome: a systematic review and follow-up study. Liver Int. 2024.
  5. Hockenberry MJ, Wilson D, Rodgers CC. Wong's Nursing Care of Infants and Children. 11th ed. St. Louis (MO): Elsevier; 2019.
  6. Orphanet. Wolcott-Rallison syndrome (ORPHA:1667) [Internet]. Paris: Orphanet; [cited 2026 Oct 16]. Available from: https://www.orpha.net

Reference

  1. Julier C, Nicolino M. Wolcott-Rallison syndrome. Orphanet J Rare Dis. 2010;5:29. doi:10.1186/1750-1172-5-29.
  2. Delepine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet. 2000;25 (4):406-409. doi:10.1038/78085.
  3. Senee V, Vattem KM, Delepine M, Rainbow LA, Haton C, Lecoq A, et al. Wolcott-Rallison syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes. 2004;53 (7):1876-1883. doi:10.2337/diabetes.53.7.1876.
  4. Aldrian S, et al. Natural history of Wolcott-Rallison syndrome: a systematic review and follow-up study. Liver Int. 2024.
  5. Hockenberry MJ, Wilson D, Rodgers CC. Wong's Nursing Care of Infants and Children. 11th ed. St. Louis (MO): Elsevier; 2019.
  6. Orphanet. Wolcott-Rallison syndrome (ORPHA:1667) [Internet]. Paris: Orphanet; [cited 2026 Oct 16]. Available from: https://www.orpha.net

Photo
Sheeba Anitha Rani
Corresponding author

Child Health Nursing Department, Driems University, School Of Nursing, Kotasahi, Tangi, Cuttack, Odisha 754022

Photo
Devi Prasan Kar
Co-author

Child Health Nursing Department, Driems University, School Of Nursing, Kotasahi, Tangi, Cuttack, Odisha 754022

Photo
Prathima Prakasam
Co-author

Child Health Nursing Department, Driems University, School Of Nursing, Kotasahi, Tangi, Cuttack, Odisha 754022

Photo
Yerni Jyothi Kolli
Co-author

Child Health Nursing Department, Driems University, School Of Nursing, Kotasahi, Tangi, Cuttack, Odisha 754022

Devi Prasan Kar, Sheeba Anitha Rani, Yerni Jyothi Kolli, Prathima Prakasam, Wolcott–Rallison Syndrome: Raising Awareness Today for Better Care Tomorrow – A Case Report, Int. J. Sci. R. Tech., 2026, 3 (10), 1273-1277. https://doi.org/10.5281/zenodo.23663094

More related articles
Cyber Security Awareness Among Genz...
J. Anurushmitha, J. P. Pramod, D. Nikhitha...
The Courage to Live with Shwachman–Diamond Syndr...
Sheeba Anitha Rani, Yerni Jyothi Kolli, Prathima Prakasam, Ananya...
Related Articles
A Study To Assess The Level Of Awareness And Utilization Of Maternal Health Prog...
Nitin Gangwar, Vaibhav Singh , Tarun Dhyani , Nikita Singh , Nikita Baroi , Nikhil Kumar...
Association of Serum Uric Acid with Glycemic Status and Metabolic Syndrome...
Dr. Kohinoor Acharya, Dr. Sushree Swasati , Dr. Sonali Priyadarshini Sahu, Dr. Shree Mishra, Dr. Mal...
Cyber Security Awareness Among Genz...
J. Anurushmitha, J. P. Pramod, D. Nikhitha...
More related articles
Cyber Security Awareness Among Genz...
J. Anurushmitha, J. P. Pramod, D. Nikhitha...
The Courage to Live with Shwachman–Diamond Syndrome: Understanding and Caring ...
Sheeba Anitha Rani, Yerni Jyothi Kolli, Prathima Prakasam, Ananya Nath...
Cyber Security Awareness Among Genz...
J. Anurushmitha, J. P. Pramod, D. Nikhitha...
The Courage to Live with Shwachman–Diamond Syndrome: Understanding and Caring ...
Sheeba Anitha Rani, Yerni Jyothi Kolli, Prathima Prakasam, Ananya Nath...